Mariner
GPCR icon

Mariner’s Structure Therapeutics GPCR Stock Holding History

Mariner’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
46,285
+11,805
+34% +$522K ﹤0.01% 1361
2026
Q1 		$1.66M Sell
34,480
-9,675
-22% -$662K ﹤0.01% 1630
2025
Q4 		$3.07M Buy
44,155
+19
+0% +$776 ﹤0.01% 1253
2025
Q3 		$1.24M Buy
44,136
+4,635
+12% +$92.3K ﹤0.01% 1745
2025
Q2 		$819K Buy
39,501
+21,450
+119% +$472K ﹤0.01% 1956
2025
Q1 		$312K Sell
18,051
-6,479
-26% -$159K ﹤0.01% 2590
2024
Q4 		$665K Buy
+24,530
New +$870K ﹤0.01% 1950

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mariner's GPCR Position: Q2 2026 in Review

Mariner increased its Structure Therapeutics (GPCR) stake by 34% in Q2 2026, buying an estimated $522K and bringing the position to 46,285 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

Mariner first reported a position in GPCR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.07M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Mariner held 46,285 shares of Structure Therapeutics worth $2.48M as of Q2 2026.
  • Mariner bought 11,805 Structure Therapeutics shares in Q2 2026, an estimated $522K.
  • Structure Therapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1361 holding.
  • Mariner first reported a position in Structure Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mariner's Structure Therapeutics position peaked at $3.07M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.